Cellply
Italy
- Bologna, Em.Rom
- 02/10/2023
- Unknown
- $3,794,000
Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics.
Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments.
Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.
- Industry Biotechnology Research
- Website https://cellply.com/
- LinkedIn https://www.linkedin.com/company/cellply/about/
Related People
Massimo BocchiFounder
Italy -
Bologna, Emilia-Romagna
- Scientific expertise in the field of microsystems for biotech applications, leadership experience on research teams and projects, strong dedication to technology entrepreneurship
- 10 years research experience on microelectronics and microsystems for life science applications with more than 20 publications appeared on international scientific journals and conference proceedings.
- Inventor of 8 patent families about microtechnologies for cell manipulation and innovative methods for drug discovery.
- Experience on research projects for development of innovative microsystems involving many scientific areas, including electronics, biology, chemistry, mechanics, fluid dynamics, thermal dynamics, physics.
- Project planning and management of multidisciplinary teams, coordination of international research projects.
- Technical skills on computer programming, CAD for microelectronics and electronic circuit design, FEM simulators, project management software tools.
Specialties: Technology entrepreneurship, microsystem design and engineering, cell manipulation, lab-on-a-chip technologies, microfluidics, research team management, research project proposals, IP protection.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)